Project #78: Mechanisms and Delivery of FGF19 in Type 1 Diabetes
Forecasted
This grant supports research on how FGF19 therapies could prevent or treat type 1 diabetes, emphasizing novel mechanisms and delivery strategies.
Funder: Diabetes Research Connection
Due Dates (Anticipated): July 2027 (RFA opening & closing; full application deadline, projected)
Funding Amounts: Up to $75,000 per project for one year; graduate students eligible for up to $50,000.
Summary: Supports early-career researchers investigating innovative approaches for type 1 diabetes prevention, cure, or management.
Key Information: Only early-career U.S.-based scientists are eligible; research must focus on type 1 diabetes.
Description
This opportunity provides seed funding for early-career scientists exploring innovative research in type 1 diabetes (T1D), specifically supporting projects such as the investigation of FGF19-based therapies for T1D prevention or delay. The program is designed to fund novel, early-stage research that may not yet be competitive for large-scale grants, with a strong emphasis on bold ideas that address the prevention, cure, or improved management of T1D and its complications. The Diabetes Research Connection (DRC) utilizes a donor-driven, peer-reviewed model to connect promising young investigators with funding, aiming to accelerate the discovery of new T1D treatments.
